Clinical Trial Update: A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetic profile, safety, and tolerability of ME1100 Inhalation Solution in patients with mechanically ventilated bacterial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Pneumonia

Drugs mentioned

• ME1100 Inhalation Solution

Snippet

Sponsor: Meiji Seika Pharma Co., Ltd. | Conditions: Pneumonia, Bacterial | Phase 1 | Status: COMPLETED